Novavax, Inc. (NASDAQ:NVAX) Q1 2026 Earnings Call Transcript May 6, 2026
Novavax, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.25.
James Kelly: Good morning, and thank you for joining us today to discuss our first quarter 2026 financial results and operational highlights. A press release announcing our results is available on our website at novavax.com, and an audio archive of this conference call will be available on our website later today. Please turn to...
